Analysis of Pregnant Women Recovered From Antenatal SARS-CoV-2 Infection: An Observational Study
Open Access
- 10 February 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e22094
Abstract
The global health care system is facing the challenge of diagnosing and treating the ongoing coronavirus disease 2019 (COVID-19) pandemic. Pregnant women belong to a vulnerable group, and the effect of the virus on the mother and fetus is not well established. The aim of the study was to understand the maternal and fetal outcomes after recovery from antenatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This was a retrospective observational study conducted at Tata Main Hospital, Jamshedpur, India. It included all COVID-19-negative pregnant women who had delivered between 1st January 2021 and 31st August 2021 and had tested positive in the antenatal period (by reverse transcription-polymerase chain reaction (RT-PCR)), the details of which are available in the hospital database. A total of 53 women were included in our study who had tested positive in the antenatal period and had turned negative during delivery. Out of the 53 women, 5.7% were infected in the first trimester, 34% in the second trimester, and 60.3% were positive in the third trimester. We found an asymptomatic subgroup in 52.8% of women and mild symptoms in 41.5% of women. Two women were admitted in their antenatal period with moderate COVID-19 disease and one with severe. Preterm births between 34 weeks and 37 weeks were seen in 26.4% of women. Vaginal delivery accounted for 30.2% of cases. The most common indications for cesarean section were fetal distress (17%), previous cesarean section (17%), and unwillingness for vaginal delivery. Out of the 53 pregnant women included in the study, acute respiratory distress syndrome (ARDS) was seen in two women- one diagnosed intraoperatively during cesarean section and the other was diagnosed on the first postoperative day. The study showed that pregnant women infected with SARS-CoV-2 usually have no/mild symptoms, and they recover well and have favorable maternal and neonatal outcomes. However, perinatal vigilance is advisable in these cases, as there is a risk of developing respiratory morbidity.Keywords
This publication has 14 references indexed in Scilit:
- Doppler assessment of the fetus in pregnant women recovered from COVID‐19Journal of Obstetrics and Gynaecology Research, 2021
- No obviously adverse pregnancy complications and outcomes of the recovered pregnant women from COVID-19Reproductive Toxicology, 2021
- An Immunological Perspective: What Happened to Pregnant Women After Recovering From COVID-19?Frontiers in Immunology, 2021
- COVID-19 in pregnancy and the puerperium: A review for emergency physiciansThe American Journal of Emergency Medicine, 2021
- Impact of COVID-19 on PregnancyInternational Journal of Medical Sciences, 2021
- Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 InfectionJAMA Network Open, 2020
- Successful continuation of pregnancy in a patient with COVID-19-related ARDSBMJ Case Reports, 2020
- Is pregnancy an immunological contributor to severe or controlled COVID‐19 disease?American Journal of Reproductive Immunology, 2020
- Coronavirus Disease 2019 in Pregnancy: A Clinical Management Protocol and Considerations for PracticeFetal Diagnosis and Therapy, 2020
- Clinical update onCOVID‐19 in pregnancy: A review articleJournal of Obstetrics and Gynaecology Research, 2020